Cargando…
ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV
Novel therapeutic strategies are needed to attenuate increased systemic and gut inflammation that contribute to morbidity and mortality in chronic HIV infection despite potent antiretroviral therapy (ART). The goal of this study is to use preclinical models of chronic treated HIV to determine whethe...
Autores principales: | Daskou, Maria, Mu, William, Sharma, Madhav, Vasilopoulos, Hariclea, Heymans, Rachel, Ritou, Eleni, Rezek, Valerie, Hamid, Philip, Kossyvakis, Athanasios, Sen Roy, Shubhendu, Grijalva, Victor, Chattopadhyay, Arnab, Kitchen, Scott G., Fogelman, Alan M., Reddy, Srinivasa T., Kelesidis, Theodoros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740974/ https://www.ncbi.nlm.nih.gov/pubmed/34995311 http://dx.doi.org/10.1371/journal.ppat.1010160 |
Ejemplares similares
-
ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV
por: Daskou, M., et al.
Publicado: (2021) -
The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells
por: Theodoros, Kelesidis, et al.
Publicado: (2021) -
Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer
por: Chattopadhyay, Arnab, et al.
Publicado: (2018) -
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
por: Cedó, Lídia, et al.
Publicado: (2016) -
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)